Genetic predisposition to mosaic Y chromosome loss in blood

Journal: Nature

Published: 2019-11-20

DOI: 10.1038/s41586-019-1765-3

Affiliations: 35

Authors: 51

Go to article
Institutions Share
Science for Life Laboratory (SciLifeLab), Sweden 0.13
MRC Epidemiology Unit, University of Cambridge, United Kingdom (UK) 0.11
deCODE Genetics, Inc., Iceland 0.11
ICR Division of Genetics and Epidemiology, United Kingdom (UK) 0.09
Centre for Cancer Genetic Epidemiology (CCGE), University of Cambridge, United Kingdom (UK) 0.08
NIH NCI Division of Cancer Epidemiology and Genetics (DCEG), United States of America (USA) 0.06
23andMe, Inc., United States of America (USA) 0.04
Faculty of Pharmacy with Subfaculty of Laboratory Medicine, MUG, Poland 0.04
Program in Medical and Population Genetics, Broad Institute, United States of America (USA) 0.03
Department of Cell Biology, JHU, United States of America (USA) 0.02
University of Exeter Medical School (UEMS), United Kingdom (UK) 0.02
Division of Molecular Pathology, UTokyo, Japan 0.02
Department of Public Health and Caring Sciences (IFV), UU, Sweden 0.02
Center for Chromosome Stability (CCS), UCPH, Denmark 0.02
Faculty of Medicine, University of Iceland, Iceland 0.02
Institute of Cancer and Genomic Sciences, UB, United Kingdom (UK) 0.02
Department of Internal Medicine, Erasmus MC, Netherlands 0.02
Harvard Department of Genetics, United States of America (USA) 0.01
Stanley Center for Psychiatric Research, Broad Institute, United States of America (USA) 0.01
RIKEN Laboratory for Statistical and Translational Genetics, Japan 0.01
RIKEN Laboratory for Statistical Analysis, Japan 0.01
School of Engineering and Natural Sciences (SENS), University of Iceland, Iceland 0.01
Wellcome Trust/Cancer Research UK Gurdon Institute (The Gurdon Institute), University of Cambridge, United Kingdom (UK) 0.01
Division of Genetics, BWH, United States of America (USA) 0.01
Department of Biochemistry, University of Cambridge, United Kingdom (UK) 0.01
Harvard Biological and Biomedical Sciences Progam (BBS), United States of America (USA) 0.01
William Harvey Research Institute (WHRI), QMUL, United Kingdom (UK) 0.01
Sanger Institute Centre for Therapeutic Target Validation (Open Targets), United Kingdom (UK) 0.01
Western General Hospital, NHS Lothian, United Kingdom (UK) 0.01
MRC Institute of Genetics and Molecular Medicine (IGMM), United Kingdom (UK) 0.01
Beijer Laboratory of Genome Research, UU, Sweden 0.01
Kyoto-McGill International Collaborative Program in Genomic Medicine, Japan 0.01
School of Pharmaceutical Sciences / Graduate Division of Pharmaceutical Sciences, University of Shizuoka, Japan 0
Clinical Research Center, Shizuoka General Hospital, Japan 0

Return